2018-03-15 07:41:00 Thu ET
treasury deficit debt employment inflation interest rate macrofinance fiscal stimulus economic growth fiscal budget public finance treasury bond treasury yield sovereign debt sovereign wealth fund tax cuts government expenditures
The Trump administration's $1.5 trillion hefty tax cuts and $1 trillion infrastructure expenditures may speed up the Federal Reserve interest rate hike due to robust labor market growth. The U.S. economy adds more than 313,000 non-farm payroll jobs in early-2018. The stellar key labor market growth is stronger than most macro projections, and the U.S. unemployment rate stays at 4.1% or the lowest level in 17 years. Wages also grow at 2.6% and remain a few notches below the prior pace. Productive progress in U.S. employment and economic output continues without higher inflation near the 2% target. In accordance with most macro expectations, the Federal Reserve expects to raise interest rate 4 times in 2018 and maybe 3-4 times in 2019. The current neutral interest rate hike helps attain the congressional dual mandate of maximum employment and price stability.
Senate majority leader Mitch McConnell announces the new budget deal. This deal can be sustainable with $15 trillion national debt and $80-$95 billion budget deficit projections over the next 2 years. A key issue concerns how long Congress should raise the national debt limit, which the U.S. economy may hit as soon as April 2018. Republicans and Democrats still need to negotiate the exact parameters to reach bipartisan agreement.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2018-08-21 11:40:00 Tuesday ET

President Trump criticizes his new Fed Chair Jerome Powell for accelerating the current interest rate hike with greenback strength. This criticism overshado
2019-01-05 11:39:00 Saturday ET

Reuters polls show that most Americans blame President Trump for the recent U.S. government shutdown. President Trump remains adamant about having to shut d
2023-06-28 09:29:00 Wednesday ET

Carmen Reinhart and Kenneth Rogoff delve into several centuries of cross-country crisis data to find the key root causes of financial crises for asset marke
2023-10-14 10:32:00 Saturday ET

Jonathan Baker frames the current debate over antitrust merger review and enforcement in America. Jonathan Baker (2019) The antitrust paradi
2023-01-03 09:34:00 Tuesday ET

USPTO fintech patent protection and accreditation As of early-January 2023, the U.S. Patent and Trademark Office (USPTO) has approved